MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial

Kenji Ikemura1, Misato Yamamoto, Saori Miyazaki

  • 1College of Pharmacy, Kinjo Gakuin University, Nagoya, Aichi, Japan.

Molecular Pharmacology
|November 21, 2012
PubMed

Insights

Liver ischemia-reperfusion injury decreases microRNA-145 (miR-145) levels, leading to increased P-glycoprotein (P-gp) expression in the intestine. This study reveals miR-145 as a key regulator of intestinal P-gp post-transcriptionally.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Gastroenterology

Background:

  • P-glycoprotein (P-gp/MDR1) is a crucial drug efflux transporter affecting drug pharmacokinetics.
  • Intestinal P-gp expression increases after liver ischemia-reperfusion (I/R) injury, but regulatory mechanisms are unclear.
  • MicroRNAs (miRNAs) are known regulators of drug transporter expression.

Purpose of the Study:

  • To investigate intestinal miRNA expression changes following liver I/R injury.
  • To elucidate the role of miRNAs in the post-transcriptional regulation of intestinal P-gp.
  • To identify specific miRNAs involved in modulating P-gp expression after liver I/R.

Main Methods:

  • Microarray analysis and real-time PCR to profile intestinal miRNA expression in I/R rats.
  • In silico analysis to predict miRNA binding sites on Mdr1 mRNA 3'-UTRs.
  • Luciferase reporter assays in HEK293 cells to validate miR-145 interaction with MDR1 3'-UTR.
  • Experiments in Caco-2 cells to assess the impact of miR-145 modulation on P-gp expression and function.

Main Results:

  • MicroRNA-145 (miR-145) levels were significantly downregulated in the small intestine of I/R rats.
  • In silico and luciferase assays confirmed direct binding of miR-145 to the 3'-UTR of MDR1 mRNA.
  • Downregulation of miR-145 in Caco-2 cells increased P-gp expression and efflux activity, without altering MDR1 mRNA levels.
  • These findings indicate miR-145 negatively regulates P-gp expression and function.

Conclusions:

  • miR-145 directly represses P-gp expression and function via interaction with the MDR1 mRNA 3'-UTR.
  • The observed downregulation of miR-145 contributes to elevated intestinal P-gp expression post-liver I/R.
  • This study provides novel insights into the post-transcriptional regulation of intestinal P-gp by miRNAs.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...